NHS

Chr XXLDX-linked

NHS actin remodeling regulator

Also known as: CTRCT40, CXN

This gene encodes a protein containing four conserved nuclear localization signals. The encoded protein functions in eye, tooth, craniofacial and brain development, and it can regulate actin remodeling and cell morphology. Mutations in this gene have been shown to cause Nance-Horan syndrome, and also X-linked cataract-40. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, May 2014]

Primary Disease Associations & Inheritance

Nance-Horan syndromeMIM #302350
XLD
Cataract 40, X-linkedMIM #302200
X-linked
Nance-Horan syndromeMIM #302350
XLD
12
Active trials
47
Pathogenic / LP
359
ClinVar variants
3394
Pubs (1 yr)
1.8
Missense Z
0.09
LOEUF· LoF intolerant
Clinical SummaryNHS
🧬
Gene-Disease Validity (ClinGen)
Nance-Horan syndrome · XLDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
47 Pathogenic / Likely Pathogenic· 186 VUS of 359 total submissions
💊
Clinical Trials
12 active or recruiting trials — potential therapeutic options may be available
📖
GeneReview available — NHS
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint
0.09LOEUF
pLI 1.000
Z-score 5.42
OE 0.00 (0.000.09)
Highly constrained

Among the most LoF-intolerant genes (~top 3%)

Missense Constraint
1.82Z-score
OE missense 0.79 (0.740.86)
495 obs / 623.0 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.00 (0.000.09)
00.351.4
Missense OE0.79 (0.740.86)
00.61.4
Synonymous OE0.90
01.21.6
LoF obs/exp: 0 / 34.1Missense obs/exp: 495 / 623.0Syn Z: 1.30
LOF
DN
0.2299th %ile
GOF
0.3689th %ile
LOF
0.86top 5%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · 47% of P/LP variants are LoF · LOEUF 0.09

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

359 submitted variants in ClinVar

Classification Summary

Pathogenic34
Likely Pathogenic13
VUS186
Likely Benign90
Benign31
Conflicting5
34
Pathogenic
13
Likely Pathogenic
186
VUS
90
Likely Benign
31
Benign
5
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
12
0
22
0
34
Likely Pathogenic
10
0
3
0
13
VUS
0
169
16
1
186
Likely Benign
1
24
10
55
90
Benign
0
11
4
16
31
Conflicting
5
Total232045572359

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

NHS · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

NHS-related Nance-Horan syndrome

definitive
Monoallelic X HemizygousLoss Of FunctionAbsent Gene Product
Dev. DisordersEye
G2P ↗

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

ObesityPreDiabetes

The Effect of Time-Restricted Eating in Cardiometabolic Health

RECRUITING
NCT05866406Phase NACambridge University Hospitals NHS Foundation TrustStarted 2023-11-01
Time restricted eatingExtended eating windowHealthy diet
Autosomal Dominant Polycystic Kidney Disease (ADPKD

Hypertension in Children and Young People at Risk of Autosomal Dominant Polycystic Kidney Disease

RECRUITING
NCT07260071King's College LondonStarted 2025-08-15
Pompe DiseasePompe Disease (Late-onset)Glycogen Storage Disease Type 2

A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE)

ACTIVE NOT RECRUITING
NCT04093349Phase PHASE1, PHASE2Spark Therapeutics, Inc.Started 2020-10-01
SPK-3006
Diabetes MellitusMonogenic DiabetesHyperinsulinism

Understanding Beta Cell Disorders Through the Study of Rare Genotypes (ENDURE)

RECRUITING
NCT06478121University of ExeterStarted 2025-11-11
Data and Blood collectionMRI
Irritable Bowel Syndrome (IBS)Sucrase Isomaltase Deficiency

Genetic Carbohydrate Maldigestion as a Model to Study Food Hypersensitivity

ACTIVE NOT RECRUITING
NCT05795049Nottingham University Hospitals NHS TrustStarted 2024-07-23
Stool and saliva sample collectionQuestionnaire completion
P47-Phox, Deficiency of

Lentiviral Gene Therapy for p47 AR-CGD

RECRUITING
NCT05207657Phase PHASE1, PHASE2Great Ormond Street Hospital for Children NHS Foundation TrustStarted 2023-03-20
Lentiviral vector transduced CD34+ cells
Obesity

Intensive Weight Loss Intervention Versus Usual Care for Adults With Severe and Complex Obesity

RECRUITING
NCT06321458Phase NACarsten DirksenStarted 2024-04-29
Intensive weight loss interventionUsual care
Huntington Disease

Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers

RECRUITING
NCT06667414Hoffmann-La RocheStarted 2024-09-02
Hypertrophic Cardiomyopathy

HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy

ACTIVE NOT RECRUITING
NCT01915615University of VirginiaStarted 2014-04
None - this is an observational study
Cerebral Palsy

NeuralNET Cerebral Palsy Pilot Study

ACTIVE NOT RECRUITING
NCT05858268University of CambridgeStarted 2023-04-14
Whole-genome sequencing
Systemic Lupus Erythematosus

Establishing the Salience of Type 1 Interferon Pathway Blockade in the Central Mechanisms of SLE Related Fatigue

NOT YET RECRUITING
NCT06784076NHS Greater Glasgow and ClydeStarted 2025-03-17
Anifrolumab
Wilson Disease

A Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson Disease

ACTIVE NOT RECRUITING
NCT04884815Phase PHASE1, PHASE2Ultragenyx Pharmaceutical IncStarted 2021-09-27
UX701Standard of Care (SOC)
Clinical Literature
Landmark / reviewRecent case evidence
Key Publications
Landmark & review papers · by relevance
PubMed
Top 5 results · since 2015Search PubMed ↗